Amarin Corp Plc (AMRN)

[Chromosome]

You have an impressive memory Kiwi…yes was at ZSPH through the acquisition and two CRL’s followed by shuttering the San Mateo site. AZ paid 2.7 b for us; Lokelma was the superior drug for hyperkalemia due to rapid lowering of K+…they were projected to do a billion at peak and are at 400 now so many years after because of the delay in launch. Goes to show, all things being equal, market order entry goes 50- 60% share for 1st to market, 20 to 30% for second and 10 to 20% for third.
Back to AMRN, I have seen again and again that ultimately the science will prevail. Still long 92K shares.